company background image
PHAR

Dar Al-Shifa Pharmaceuticals PLSE:PHARMACARE Stock Report

Last Price

US$3.35

Market Cap

US$30.2m

7D

0%

1Y

6.3%

Updated

18 Mar, 2023

Data

Company Financials

Dar Al-Shifa Pharmaceuticals Company

PLSE:PHARMACARE Stock Report

Market Cap: US$30.2m

PHARMACARE Stock Overview

Dar Al-Shifa Pharmaceuticals Company manufactures, markets, and distributes medicines and chemicals in West Bank and Gaza Strip.

PHARMACARE fundamental analysis
Snowflake Score
Valuation3/6
Future Growth0/6
Past Performance3/6
Financial Health4/6
Dividends2/6

Dar Al-Shifa Pharmaceuticals Company Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Dar Al-Shifa Pharmaceuticals
Historical stock prices
Current Share PriceUS$3.35
52 Week HighUS$3.35
52 Week LowUS$2.97
Beta-0.013
1 Month Change0%
3 Month Changen/a
1 Year Change6.31%
3 Year Change0.24%
5 Year Change-6.44%
Change since IPO-22.04%

Recent News & Updates

Recent updates

Shareholder Returns

PHARMACAREPS PharmaceuticalsPS Market
7D0%1.6%-0.4%
1Y6.3%3.5%-15.4%

Return vs Industry: PHARMACARE exceeded the PS Pharmaceuticals industry which returned 0.7% over the past year.

Return vs Market: PHARMACARE exceeded the PS Market which returned -8.9% over the past year.

Price Volatility

Is PHARMACARE's price volatile compared to industry and market?
PHARMACARE volatility
PHARMACARE Average Weekly Movementn/a
Pharmaceuticals Industry Average Movement5.3%
Market Average Movement3.5%
10% most volatile stocks in PS Market5.4%
10% least volatile stocks in PS Market2.7%

Stable Share Price: PHARMACARE has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine PHARMACARE's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
1986423Bassim Subhi Farah Nasrn/a

Dar Al-Shifa Pharmaceuticals Company manufactures, markets, and distributes medicines and chemicals in West Bank and Gaza Strip. The company offers various human medicines, such as pills, capsules, creams, and liquids, as well as veterinary treatment products. Dar Al-Shifa Pharmaceuticals Company was founded in 1986 and is headquartered in Ramallah, the Palestinian Authority.

Dar Al-Shifa Pharmaceuticals Company Fundamentals Summary

How do Dar Al-Shifa Pharmaceuticals's earnings and revenue compare to its market cap?
PHARMACARE fundamental statistics
Market capUS$30.15m
Earnings (TTM)US$4.87m
Revenue (TTM)US$30.71m

6.2x

P/E Ratio

1.0x

P/S Ratio

Is PHARMACARE overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
PHARMACARE income statement (TTM)
RevenueUS$30.71m
Cost of RevenueUS$17.62m
Gross ProfitUS$13.09m
Other ExpensesUS$8.23m
EarningsUS$4.87m

Last Reported Earnings

Dec 31, 2021

Next Earnings Date

n/a

Earnings per share (EPS)0.54
Gross Margin42.63%
Net Profit Margin15.85%
Debt/Equity Ratio74.0%

How did PHARMACARE perform over the long term?

See historical performance and comparison

Dividends

2.9%

Current Dividend Yield

18%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.